Minireviews
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 99241
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99241
Table 2 Retrospective studies published during 2019-2020 on venous thromboembolism following lung transplantation, n (%)
Ref.
Study groups
LT patients
VTE
PE/infarct
DVT
Risk factors
Survival
Remarks
Zheng et al[22], 2020SLT: 143; DLT: 7819747 (23)NANAProphylaxis interruptionNAUL DVT: 55% and VTE 70% in 30 days
Jorge et al[23], 2020Group I (2005-2008): No DVT screening. Group II (2008-2014): DVT screeningNANANANAHigh cholesterol had 6.9 times risk of DVTBetter survival in group II due to routine screeningNA
Zhao et al[31], 2019SLT: 78; DLT: 4612432 (26)4 (3)30 (97)ECMONA2 patients had both PE and DVT. No effect due to PICC
Fan et al[24], 2019NA31619 (6)NANAAge, SLT, long ICU stayNAVTE much higher without prophylaxis